←
Lipham1,802 posts
Lipham avatar

Lipham

@liphamjohn

John C. Lipham, M.D. Professor & Chief of the Division of Upper GI and Gen Surgery, Keck School of Medicine USC. Past President of the American Foregut Society

◷ Joined May 2019▧ 61 Photos and videos
Shahin Ayazi avatar
⟳ Lipham retweeted
Shahin Ayazi@Sayazi·Nov 8

🔬 Does H. pylori infection influence progression of Barrett’s esophagus? 📊 In our study published in @JournalofGISurg, involving 266,856 patients with nondysplastic Barrett’s esophagus: 📉 H. pylori infection was associated with lower progression to dysplasia or esophageal adenocarcinoma (3.9% vs 8.3%). 🎯 Potential implications for risk stratification. 🔗 doi.org/10.1016/j.gassur.202… @SSATNews @SAGES_Updates @sepdigestiva @CelestinoGutirr @NeilFlochMD @sminaev2015 @stevenbollipo @drkeithsiau @CarlKayMD #BarrettsEsophagus #GERD

Post attachment
SurgeOn avatar
⟳ Lipham retweeted
SurgeOn@surgeonapp1·Nov 3

What do long-term outcomes reveal about the role of LINX in GERD management? Join us tomorrow at 8 PM ET for “LINX for GERD Management in 2026,” featuring Dr. Christopher DuCoin (@chrisducoin) and Dr. John Lipham (@liphamjohn), moderated by Dr. Tarek Hassab (@TarekHassabMD). Explore expert insights into patient selection, safety, and the long-term evidence surrounding LINX therapy. Don't miss this opportunity to hear directly from experienced surgeons and gain a deeper understanding of the clinical considerations behind LINX. Tune in live! This webinar is sponsored by Johnson & Johnson MedTech (@JNJMedTech). Event Link: share.surgeonapp.com/public/… #SurgeOn #GERD #LINX #GERDManagement #SurgicalEducation

Post attachment
SurgeOn avatar
⟳ Lipham retweeted
SurgeOn@surgeonapp1·Oct 28

When it comes to GERD treatment, how do surgeons determine which patients are right for LINX? Join us on November 4 at 8 PM ET for “LINX for GERD Management in 2026,” featuring Dr. Christopher DuCoin (@chrisducoin) and Dr. John Lipham (@liphamjohn), moderated by Dr. Tarek Hassab (@TarekHassabMD). Explore expert perspectives on patient selection, safety considerations, and long-term outcomes associated with LINX therapy. Gain valuable insights into the clinical decisions shaping GERD management. Don't miss this expert-led discussion! This webinar is sponsored by Johnson & Johnson MedTech (@JNJMedTech). Event Link: share.surgeonapp.com/public/… #SurgeOn #LINX #GERD #GERDManagement #SurgicalEducation

Post attachment
SurgeOn avatar
⟳ Lipham retweeted
SurgeOn@surgeonapp1·Oct 30

LINX for GERD: What should surgeons know beyond the procedure itself? Join us on November 4 at 8 PM ET as Dr. Christopher DuCoin (@chrisducoin) and Dr. John Lipham (@liphamjohn), moderated by Dr. Tarek Hassab (@TarekHassabMD), examine the role of LINX in modern GERD management, focusing on patient selection, safety, and long-term clinical outcomes. From evaluating appropriate candidates to understanding long-term results, this discussion brings valuable perspectives to an important surgical topic. Hear directly from experienced surgeons and expand your understanding of LINX therapy. Join the conversation! This webinar is sponsored by Johnson & Johnson MedTech (@JNJMedTech). Event Link: share.surgeonapp.com/public/… #SurgeOn #LINX #GERD #MinimallyInvasiveSurgery #SurgicalEducation

Post attachment
The American Foregut Society avatar
⟳ Lipham retweeted
The American Foregut Society@ForegutSociety·Oct 21

Save the date for the 2027 AFS Annual Meeting! We're excited to announce that next year's meeting will be held at the Gaylord Rockies Resort and Convention Center in Aurora, Colorado, from September 14-19, 2027. Additional details will be available soon! #AFS #AFS2027 #foregut

Post attachment
The American Foregut Society avatar
⟳ Lipham retweeted
The American Foregut Society@ForegutSociety·Oct 19

Read the AFS Journal article 'Enhancing ERAS With Fosaprepitant or Fosaprepitant + Paragastric Autonomic Nerve Blockade' by Iris G. Vallavanatt, Christopher Janssen, Micah Thomas, Monia Yovic, Janelle M. Jakobi, Gabriel Arevalo, and Todd A. Worley. 🔗 zurl.co/c6QD3.

Post attachment
The American Foregut Society avatar
⟳ Lipham retweeted
The American Foregut Society@ForegutSociety·Oct 7

Thank you to everyone who attended the 2026 AFS Annual Meeting! It was great to connect with you all. Thank you to all of our incredible speakers, sponsors, and exhibitors for helping make this year's meeting a success. Until next time! #AFS2026

Post attachmentPost attachmentPost attachmentPost attachment
Lucid Diagnostics avatar
⟳ Lipham retweeted
Lucid Diagnostics@LucidDiag·Oct 2

Esophageal cancer claims more American lives each year than melanoma and cervical cancer combined. Yet it receives only a fraction of the public awareness. Too often, it's diagnosed only after symptoms appear, when treatment options are more limited. The goal isn't to detect cancer—it's to find precancer first. Barrett's esophagus—the precancerous condition that can lead to esophageal adenocarcinoma—can be detected, monitored, and treated before cancer develops. EsoGuard® helps make that possible with a non-invasive test for at-risk patients. Awareness is the first step. Early detection is what changes outcomes.

0:12